X4 Pharmaceuticals (XFOR) Current Leases (2019 - 2025)

X4 Pharmaceuticals has reported Current Leases for 7 years, with the latest figure at $994000.0 in Q4 2025.

• For the quarter ending Q4 2025, Current Leases fell 20.54% year-over-year to $994000.0; the trailing twelve-month figure through Dec 2025 stood at $994000.0 (down 20.54% YoY), and the FY2025 full-year result was $994000.0, down 20.54% from the prior year.
• Current Leases for Q4 2025 stood at $994000.0, down from $1.2 million in the prior quarter.
• The five-year high for Current Leases was $1.4 million in Q2 2025, with the low at $875000.0 in Q1 2021.
• Historically, Current Leases has averaged $1.1 million across 5 years, with a median of $1.1 million in 2022.
• Annual changes were most pronounced in 2021 — Current Leases surged 37.7% — and 2025, when it dropped 20.54%.
• X4 Pharmaceuticals' Current Leases stood at $1.1 million in 2021, then rose by 11.44% to $1.2 million in 2022, then declined by 8.26% to $1.1 million in 2023, then gained by 13.83% to $1.3 million in 2024, then declined by 20.54% to $994000.0 in 2025.
• The last three Current Leases figures came in at $994000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.